Tirzepatide is now approved for the treatment of obstructive sleep apnea, highlighting the drug class' potential in sleep medicine.

Keeping up with the GLP-1 area is a full-time job by itself. First off, you have the recent development that these drugs are ...

Novo Nordisk's collaboration with telehealth providers offers semaglutide at $499/month, enhancing access for self-paying ...

Over the past several decades, epidemiologic studies have documented declines in sperm count and quality. During the same ...

A judge denied compounders' request to keep making off-brand Wegovy and Ozempic after the FDA removed semaglutide from its shortage list.

Though retrospective, the findings provide ‘compelling’ evidence that GLP-1 receptor agonists may help prevent development ...

and semaglutide producers have until Tuesday or May 22, depending on whether they’re a state-licensed pharmacy or an outsourcing facility. That leaves a huge opening for GLP-1 supplement sellers ...

Yet the disparities by sex, race/ethnicity, and location pale in comparison to a striking overall lack of adoption.

Semaglutide - the active ingredient in medications like Ozempic and WeGovy - is only FDA approved for Type-2 diabetes, but ...

(NPR) Meanwhile, Novo Nordisk struck deals with several telehealth companies to sell its GLP-1 drug semaglutide for obesity directly to patients. (STAT) Sequel Med Tech announced plans to ...